In accordance with the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed about proceedings of the 8th Annual General Meeting of the Company held on 27th July, 2018.
The above information is a part of company’s filings submitted to BSE.